Movement improves balance and touch in older adults with type 2 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial investigates whether a 12-week exercise program, guided by a physiotherapist, can improve balance control and somatosensory function in adults aged 60+ with type 2 diabetes and impaired balance. Participants are assigned to either standard aerobic/strength training with added balance exercises or to a comparison program following international exercise guidelines without additional balance training. Outcomes include measures of balance performance, somatosensory thresholds (touch and vibration), and diabetes-related markers such as HbA1c. The study addresses diabetes-related complications that contribute to balance problems, such as neuropathy and visual changes. Recruitment is limited to Dutch-speaking adults without major neurological or significant visual impairments and who meet balance-impairment criteria.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosis of type 2 diabetes mellitus
* Age 60 years or older
* Both men and women
* Impaired balance control identified during the testing procedure for balance control, defined as a score of less than 30 seconds on the Standing on Foam with Eyes Closed test and/or less than 10 seconds on the Single Leg Stance with Eyes Open test
* Able to understand the Dutch language.

Exclusion Criteria:

* A history of central neurological disease including stroke, multiple sclerosis, Parkinson's disease, dementia or intracranial tumor
* Severe visual impairment such as blindness, cataract or glaucoma
* Physical impairment which would preclude subjects from participating in an exercise /physical activity program (e.g. orthopedic conditions, severe cardiac conditions, uncontrolled hypertension etc.)
* Need of physical or material support
* HbA1c \< 7.5% (- the aim is to include patients with an HbA1c of \<7.5%, but if the treating endocrinologist considers an HbA1c value of 7.5 - 8% desirable for medical reasons, this patient will still be included)
* Use of medication that can affect balance (e.g. sedatives, antidepressants, or antipsychotics)
* Not understanding the Dutch language

Where it's running

• Universiteit Antwerpen
  Edegem, Antwerpen, Belgium Recruiting

Study contacts

• Study coordinator: Samera El Bakkali, Master's degree
• Email: samera.elbakkali@uantwerpen.be
• Phone: 0032485203666

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Proliverenol for liver fat and insulin resistance in type 2 diabetes

  This study tests whether adding Proliverenol to standard diabetes care can improve liver fat and blood sugar control in adults with type 2 diabetes.

  Recruiting Phase 2 Universitas Sriwijaya · Palembang, South Sumatera · NCT07928661

• Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes

  This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.

  Recruiting Pamukkale University · Denizli · NCT07924436

• Safety test of NNC9836-0001 in adults with overweight/obesity or type 2 diabetes

  This study tests whether the new medicine NNC9836-0001 is safe and tolerable in adults who are overweight or have type 2 diabetes, compared to placebo.

  Recruiting Phase 1 Novo Nordisk A/S · Neuss · NCT07896109

• RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes

  This study tests the accuracy and safety of the RIGHTEST iFree 2 continuous glucose monitor in pregnant adults with type 1, type 2, or gestational diabetes.

  Recruiting Bionime Corporation · Ulm, Baden-Wurttemberg · NCT07889388

• EloraTZP for weight loss in adults with overweight/obesity and type 2 diabetes

  This trial tests whether a coformulation of eloralintide and tirzepatide helps people with obesity or overweight and type 2 diabetes lose weight compared with tirzepatide alone.

  Recruiting Phase 3 Eli Lilly and Company · Tucson, Arizona and 74 other locations · NCT07881458

• Maridebart cafraglutide vs. semaglutide for type 2 diabetes on metformin

  This trial tests whether maridebart cafraglutlide is as good as semaglutide at improving blood sugar in adults with type 2 diabetes who take metformin (with or without an SGLT-2 inhibitor).

  Recruiting at 8 sites Phase 3 Amgen · San Diego, California and 7 other locations · NCT07866066

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.